Cilostazol therapeutic class?

What therapeutic class is cilostazol in?

Cilostazol is an antiplatelet drug. It works as a phosphodiesterase (PDE) inhibitor (specifically PDE3), which raises levels of cyclic AMP in platelets and blood vessel cells, reducing platelet aggregation and causing vasodilation. As a result, it is used to improve symptoms of peripheral arterial disease (PAD), including intermittent claudication.

Is cilostazol a blood thinner?

Yes, in practice cilostazol is an antiplatelet that reduces platelet clumping, so it acts like a “blood thinner” in terms of bleeding risk and platelet inhibition. It is not classified as a classic anticoagulant (such as warfarin or direct oral anticoagulants); instead, it is an antiplatelet agent.

What is it used for therapeutically?

Cilostazol is used to improve walking distance and symptoms in patients with intermittent claudication due to peripheral arterial disease.

What related drug classes does it overlap with?

Cilostazol overlaps functionally with antiplatelet therapies (like aspirin or clopidogrel) as it reduces platelet-driven clot formation. But its mechanism is distinct because it is a PDE3 inhibitor that also causes vasodilation, which is why it is often discussed separately from other antiplatelet drugs.